Kim Jin Sil, Won Hyung Jin, Lee So Jung, Kim So Yeon, Shin Yong Moon, Kim Pyo Nyun
Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
J Ultrasound Med. 2018 Feb;37(2):447-452. doi: 10.1002/jum.14358. Epub 2017 Aug 29.
To evaluate the accuracy and safety of repeated ultrasound-guided core needle biopsy (CNB) for hepatic focal lesions and to assess the predictive factors for success of repeated CNB.
For 5 years, 3085 CNBs were performed for focal hepatic lesions using an automated biopsy gun with an 18-gauge needle. Seventy-eight patients underwent repeated CNB because of pathologically inconclusive or unexpected results. Twelve patients were excluded because of unavailable additional tissue or follow-up imaging by radiofrequency ablation (n = 5), repeated CNB greater than than 3 months after the first CNB (n = 5), and insufficient follow-up time (n = 2). Sixty-six patients were finally enrolled after the exclusion criteria were applied. We retrospectively evaluated tumor necrosis, tumor size, number of passes, lesion site, depth, tumor conspicuity, and complications. Continuous data and the total scores of the grading system were analyzed by the Student t test, and categorical data and each category were analyzed by the Fisher exact test.
The repeated CNB rate was 2.5% (78 of 3085). The diagnostic accuracy of the repeated biopsies was 83.3% (55 of 66). Comparing the diagnostic group with the nondiagnostic group, no variable (ie, size, depth, necrosis, lesion site [segment], and number of passes) had a statistically significant difference. Tumor conspicuity was a significant factor for predicting successful repeated biopsy (P < .001). The cumulative complication rate was 10.6% (7 of 66), with only minor complications.
Repeated CNB is an accurate and safe procedure for obtaining a histologic diagnosis of hepatic focal lesions if the initial biopsy fails. High tumor conspicuity showed a significant correlation with successful repeated CNB.
评估重复超声引导下肝局灶性病变粗针穿刺活检(CNB)的准确性和安全性,并评估重复CNB成功的预测因素。
在5年时间里,使用18G穿刺针的自动活检枪对肝局灶性病变进行了3085次CNB。78例患者因病理结果不明确或意外结果接受了重复CNB。12例患者因无法获得额外组织或射频消融的随访成像(n = 5)、首次CNB后超过3个月进行重复CNB(n = 5)以及随访时间不足(n = 2)而被排除。应用排除标准后,最终纳入66例患者。我们回顾性评估了肿瘤坏死、肿瘤大小、穿刺次数、病变部位、深度、肿瘤清晰度和并发症。连续数据和分级系统的总分采用Student t检验进行分析,分类数据和各分类采用Fisher精确检验进行分析。
重复CNB率为2.5%(3085例中的78例)。重复活检的诊断准确率为83.3%(66例中的55例)。将诊断组与非诊断组进行比较,没有变量(即大小、深度、坏死、病变部位[节段]和穿刺次数)有统计学显著差异。肿瘤清晰度是预测重复活检成功的重要因素(P <.001)。累积并发症发生率为10.6%(66例中的7例),均为轻微并发症。
如果初次活检失败,重复CNB是获得肝局灶性病变组织学诊断的准确且安全的方法。高肿瘤清晰度与重复CNB成功显著相关。